Actor Pratik Gandhi became a household name with his stupendous performance as Harshad Mehta in the series Scam 1992, urge everyone that it doesn’t matter which vaccine you take, as …
Covaxin
-
- News
Coronavirus live updates | Govt's expert panel allows clinical trials for third dose of Covaxin
According to Ravi Wankhedkar, member, Indian Medical Association (IMA), rural and tribal areas are facing a grim situation and have increased the incidence of infection due to malnutrition leading to …
-
Brazil’s health regulator has rejected an application to give Bharat Biotech’s Covaxin a certificate of Good Manufacturing Practices following an inspection of the company’s site in Hyderabad earlier this month. …
-
Brazil’s health regulatory agency has decided not to clear Covaxin for use at present After delays in the delivery of Covishield, supplies of Bharat Biotech’s Covaxin to Brazil too have …
-
The challenge will be in continuing the trial with 25,800 participants till 130 cases are reported when there is a surge in many States Bharat Biotech began the phase-3 trial …
- Science
Coronavirus | Covaxin Phase-2 trials show vaccine safe, induces immune response, says Lancet study
The vaccine showed better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses compared with the Phase-1 trial Covaxin, India’s indigenous COVID-19 vaccine, showed enhanced immune response as …
-
NEW DELHI : Covaxin, India’s first indigenously developed covid-19 vaccine, is yet to undergo strict evaluation by the Central Drugs Standard Control Organisation (CDSCO) to come out of the “clinical …
-
On Saturday, a total of 9,084 persons were vaccinated against COVID-19 in Tamil Nadu, taking the total figure to 1,66,130. As many as 7,120 healthcare workers and 1,964 frontline staff …
-
The Brazilian government on Wednesday said that it was negotiating with countries including India to buy 30 million doses of coronavirus vaccines. The announcement comes after Brazilian President Jair Bolsonaro …
- News
With focus on globalization of India-developed vaccines, EUA for Covaxin filed in the Philippines
As part of the globalisation of India-developed COVID-19 vaccine, India’s Bharat Biotech has applied for “Emergency Use Authorization” (EUA) in the Philippines. EUA was filed earlier this month in the …
- News
Covaxin: With focus on globalisation, Bharat Biotech files for emergency use approval in Philippines
As part of the globalization of the India-developed COVID-19 vaccine, India’s Bharat Biotech has applied for “Emergency use authorization” (EUA) in the Philippines. EUA was filed earlier this month in …
-
COVAXIN – The vaccine developed by India’s Bharat Biotech along with the National Institute of Virology is likely to work against the UK variant of the virus, a study claims. The company …
-
Nearly 1.4 lakh were vaccinated until 6 p.m. with Maharashtra polling nearly 21,751 inoculations followed by Bihar at 12,165 and Andhra Pradesh at 11,562. This brings the number in the …
-
India’s first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the results published …
-
Hyderabad: Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine Covaxin, sources said on Tuesday. Out of those …
-
Hyderabad: A quickly planned rollout of Covaxin, a Covid-19 vaccine manufactured by the city-based Bharat Biotech, was on Monday equally quickly pulled back without any explanation by the State health …
-
Vaccine-makers Bharat Biotech on Monday advised in a factsheet that people who are immuno-compromised or are taking medicines that affect their immune system should not take COVID-19 vaccine Covaxin. Bharat …
- News
Amid Reports of Side Effects, Bharat Biotech Issues Fact Sheet for Who Should Avoid Getting Covaxin Shot
Bharat Biotech on Tuesday issued a set of cautionary guidelines for people with certain conditions who, it said, should consult with their vaccine provider and preferably avoid getting the Covaxin …
-
A consent form for Covaxin, the coronavirus vaccine developed by Bharat Biotech is promising compensation to the receiver in case of “severe adverse event”. Although the vaccine has demonstrated ability …
- News
Bharat Biotech to pay compensation if Covaxin causes ‘severe adverse reaction’ in recipients – India News , Firstpost
The central licensing authority has granted permission for the sale or distribution of Covaxin for restricted use in emergency situations in public interest as an abundant caution, in clinical trial …
-
Allaying the apprehensions associated with the safety of the vaccine developed by Bharat Biotech, S. Eswara Reddy, Joint Drugs Controller, Central Drugs Standard Control Organisation (CDSCO), said on Saturday that …
-
Covaxin saw a relatively poorer response than Covishield in turnout numbers during Saturday’s inoculation drive in Maharashtra. Of 600 people, 326 (54.3 per cent) turned up for their Covaxin shot, …
-
In a letter to the medical superintendent, the doctors wrote, “The residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate …
-
Prime Minister Narendra Modi on Saturday (January 16) launched India’s coronavirus vaccination drive via video conference. Addressing the nation on this big occasion, the prime minister said, “Everyone was waiting …
-
The Resident Doctors’ Association (RDA) of the Ram Manohar Lohia Hospital in Delhi on Saturday requested the medical superintendent to vaccinate them with Oxford COVID-19 vaccine Covishield. In a letter …
-
Hyderabad: Of the two vaccines approved for emergency use in India — Covishield and Covaxin — those receiving the latter as part of the anti-Covid-19 vaccination drive, will be under …